Phase 1, multicenter, open-label study of single-agent bispecific antibody T-cell engager GBR 1342 in relapsed/refractory multiple myeloma Meeting Abstract


Authors: Richter, J. R.; Wermke, M.; Kauh, J. S.; Back, J.; Salhi, Y.; Reddy, V.; Bayever, E.; Landgren, C. O.
Abstract Title: Phase 1, multicenter, open-label study of single-agent bispecific antibody T-cell engager GBR 1342 in relapsed/refractory multiple myeloma
Meeting Title: 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 5 Suppl.
Meeting Dates: 2018 Jan 25-27
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-10
Language: English
ACCESSION: WOS:000436177700079
PROVIDER: wos
DOI: 10.1200/JCO.2018.36.5_suppl.TPS81
Notes: Meeting Abstract: TPS81 -- Source: Wos
Altmetric Score
MSK Authors
  1. Carl Ola Landgren
    175 Landgren